Manufacturing

This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.

The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.

The company has officially opened a local brand office in South Korean to support its existing business in the region.

Supply Chain Wizard has developed a set of integrated digital solutions to improve supply chain functions.

The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

Reliable, high-quality products require innovative analytics and production.

Connectors are a critical element in the process optimization of single-use bioprocessing systems.

Despite the disappointing therapeutic performance of ADCs thus far, the pipeline still boasts promising prospects.

Cole Parmer's Masterflex L/S Cytoflow pump head is suited for use in biopharma and microbiology applications.

The Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is compliant with good distribution practices and comes in three models.

Rinse sample analysis or visual inspection are risk-based approaches that can be correlated to surface cleanliness to replace surface sampling in a biopharmaceutical equipment cleaning process.

CPhI Pharma Awards honor companies and individuals driving the pharma industry forward.

Anna Kireieva/Shutterstock.comSpeed to market is essential in the biopharmaceutical industry today.

Despite GxP and data-management challenges, pharma is moving toward new models for clinical trial logistics.

Siliconization is a key process step in the manufacturing of prefilled syringe systems.

The biotechnology company has entered a contract with the United States Army to develop custom recombinant spider silk for protective textile applications.

The vaccine is approved for the prevention of shingles in adult patients aged 50 years and older.

As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.

AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.

Inovio has reported results from a study with non-human primates that showed 100% effectiveness with a DNA vaccine the company is developing with the US Army.

The use of external retainers to enhance the seal between connectors and tubing is an essential component in single-use manufacturing systems.

The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.

ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.

How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?

The biopharmaceutical company has received a $4.2-million grant from the Bill & Melinda Gates Foundation to invest in the development of new treatments for Enterotoxigenic Escherichia coli infections, a bacterial cause of diarrhea in the developing world.

The API manufacturer has announced that it has completed the expansion of large-scale manufacturing capabilities at its Charles City, Iowa site.

The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.

The clinical-stage biopharmaceutical company has announced the opening of a new gene therapy manufacturing facility in Modiin, Israel, which is anticipated to be the production site of the company’s lead cancer drug candidate.